SCHEMBL17907920

SCHEMBL17907920

COc1ccc2c(c1)cc1n2CC(=O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.51
HTR2C P28335 2/20 0.51
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 3/20 0.42
POLB P06746 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
USP2 O75604 1/20 0.40
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
GSTP1 P09211 1/20 0.37
GLA P06280 1/20 0.36
GRIK1 P39086 1/20 0.36
GRIK2 Q13002 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17907935 0.82 MAOA (0.36) HTR2AHTR2CKDM4EPOLBKMT2A
SCHEMBL17907932 0.80 SIGMAR1 (0.41) HTR2AHTR2CKDM4EALDH1A1HSD17B10
SCHEMBL9261564 0.79 NOTUM (0.57) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL13279280 0.77 SIGMAR1 (0.42) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL4048826 0.77 HTR2A (0.62) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL17907930 0.77 HTR2A (0.48) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL235219 0.74 NOTUM (0.59) HTR2AHTR2C
SCHEMBL26839172 0.73 HTR2A (0.61) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL26838992 0.72 HTR2A (0.77) HTR2AHTR2CKDM4EALDH1A1HPGD
SCHEMBL4049250 0.72 HTR2A (0.59) HTR2AHTR2CKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697223-B1 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2016-07-13 EP disclosed